Files and links (1)
Published (Version of record)CC BY-ND V4.0, Open
Magazine article
Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefits
The Conversation
02/04/2024
Appears in Recent Faculty of Health Publications
Metrics
72 Record Views
Abstract
After weight-loss drugs like Ozempic exploded onto the market, celebrities and social media influencers were quick to spruik their benefits, leading to their rapid rise in use. In the last three months of 2022, clinicians in the United States alone wrote more than nine million prescriptions for these drugs.
As they’ve grown in popularity, we’ve also heard more about the potential side effects – from common gastrointestinal discomforts, to more serious mental health concerns.
But what does the science say about how well Ozempic and Wegovy (which are both brand names of the drug semaglutide) work for weight loss? And what are the potential side effects? Here’s what to consider if you or a loved one are thinking of taking the drug.
Details
- Title
- Considering taking a weight-loss drug like Ozempic? Here are some potential risks and benefits
- Creators
- Lauren Ball - The University of QueenslandEmily Burch - Southern Cross University, Faculty of Health
- Publication Details
- The Conversation
- Publisher
- The Conversation Media Group Ltd
- Identifiers
- 991013180413302368
- Academic Unit
- Faculty of Health
- Language
- English
- Resource Type
- Magazine article